论文部分内容阅读
目的:探讨心肌损伤标志物监测在早期急性心肌梗死诊断中的临床应用价值。方法:对收治的急性心肌梗死患者采取心肌损伤标志物肌钙蛋白(IcTnI)、肌红蛋白(Myo)、肌酸激酶同工酶(CK-MB)等联合检测,并与单独检测诊断效果进行比较。结果:心肌梗死组和非典型组与对照组相比,均有明显差异(P<0.05);心肌梗死组的肌钙蛋白(IcTnI)、肌红蛋白(Myo)、肌酸激酶同工酶(CK-MB)水平明显低于非典型组。结论:联合监测Myo、cTnI、CK-MB等心肌损伤标志物,有助于提供与梗死面积有关的定性信息,为临床鉴别诊断提供参考,同时对再梗死发生、预后及观察疗效具有重要意义。
Objective: To investigate the clinical value of monitoring myocardial injury markers in the diagnosis of early acute myocardial infarction. Methods: The myocardial injury markers such as IcTnI, Myo, CK-MB were detected in patients with acute myocardial infarction. The diagnostic results were evaluated separately Compare Results: The myocardial infarction group and atypical group were significantly different from the control group (P <0.05). The levels of IcTnI, Myoglobin and creatine kinase isoenzyme CK-MB) was significantly lower than the atypical group. CONCLUSION: The combined monitoring of myocardial injury markers such as Myo, cTnI and CK-MB will help to provide qualitative information related to infarct size, provide reference for differential diagnosis, and be of great significance for the occurrence, prognosis and observation of curative effect of reinfarction.